RU2251548C2 - Производные n-(индолкарбонил)пиперазина, способы их получения, фармацевтический препарат, соединения - Google Patents

Производные n-(индолкарбонил)пиперазина, способы их получения, фармацевтический препарат, соединения Download PDF

Info

Publication number
RU2251548C2
RU2251548C2 RU2002103302/04A RU2002103302A RU2251548C2 RU 2251548 C2 RU2251548 C2 RU 2251548C2 RU 2002103302/04 A RU2002103302/04 A RU 2002103302/04A RU 2002103302 A RU2002103302 A RU 2002103302A RU 2251548 C2 RU2251548 C2 RU 2251548C2
Authority
RU
Russia
Prior art keywords
indol
methanone
formula
compounds
piperazin
Prior art date
Application number
RU2002103302/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2002103302A (ru
Inventor
Хеннинг БЁТТХЕР (DE)
Хеннинг БЁТТХЕР
Хартмут ГРАЙНЕР (DE)
Хартмут Грайнер
Юрген ХАРТИНГ (DE)
Юрген Хартинг
Герд БАРТОШИК (DE)
Герд Бартошик
Кристоф ЗЕЙФРИД (DE)
Кристоф Зейфрид
Кристоф ВАН-АМСТЕРДАМ (DE)
Кристоф ВАН-АМСТЕРДАМ
Original Assignee
Мерк Патент Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Патент Гмбх filed Critical Мерк Патент Гмбх
Publication of RU2002103302A publication Critical patent/RU2002103302A/ru
Application granted granted Critical
Publication of RU2251548C2 publication Critical patent/RU2251548C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
RU2002103302/04A 1999-07-22 2000-07-07 Производные n-(индолкарбонил)пиперазина, способы их получения, фармацевтический препарат, соединения RU2251548C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19934433.7 1999-07-22
DE19934433A DE19934433A1 (de) 1999-07-22 1999-07-22 N-(Indolcarbonyl-)piperazinderivate

Publications (2)

Publication Number Publication Date
RU2002103302A RU2002103302A (ru) 2003-11-10
RU2251548C2 true RU2251548C2 (ru) 2005-05-10

Family

ID=7915702

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002103302/04A RU2251548C2 (ru) 1999-07-22 2000-07-07 Производные n-(индолкарбонил)пиперазина, способы их получения, фармацевтический препарат, соединения

Country Status (26)

Country Link
US (2) US6838461B1 (cg-RX-API-DMAC10.html)
EP (1) EP1198453B9 (cg-RX-API-DMAC10.html)
JP (2) JP5242871B2 (cg-RX-API-DMAC10.html)
KR (1) KR100779207B1 (cg-RX-API-DMAC10.html)
CN (1) CN1229345C (cg-RX-API-DMAC10.html)
AR (1) AR024819A1 (cg-RX-API-DMAC10.html)
AT (1) ATE236877T1 (cg-RX-API-DMAC10.html)
AU (1) AU770411B2 (cg-RX-API-DMAC10.html)
BR (1) BR0012607A (cg-RX-API-DMAC10.html)
CA (1) CA2383779C (cg-RX-API-DMAC10.html)
CZ (1) CZ300510B6 (cg-RX-API-DMAC10.html)
DE (2) DE19934433A1 (cg-RX-API-DMAC10.html)
DK (1) DK1198453T5 (cg-RX-API-DMAC10.html)
ES (1) ES2192535T3 (cg-RX-API-DMAC10.html)
HK (1) HK1048636B (cg-RX-API-DMAC10.html)
HU (1) HUP0201988A3 (cg-RX-API-DMAC10.html)
MX (1) MXPA02000730A (cg-RX-API-DMAC10.html)
MY (1) MY122531A (cg-RX-API-DMAC10.html)
NO (1) NO322154B1 (cg-RX-API-DMAC10.html)
PL (1) PL201893B1 (cg-RX-API-DMAC10.html)
PT (1) PT1198453E (cg-RX-API-DMAC10.html)
RU (1) RU2251548C2 (cg-RX-API-DMAC10.html)
SK (1) SK286066B6 (cg-RX-API-DMAC10.html)
UA (1) UA73518C2 (cg-RX-API-DMAC10.html)
WO (1) WO2001007435A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA200201486B (cg-RX-API-DMAC10.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12398130B2 (en) 2016-02-25 2025-08-26 Asceneuron Sa Acid addition salts of piperazine derivatives
RU2851014C2 (ru) * 2021-07-05 2025-11-17 Феррер Интернасионал, С.А. Лекарственные средства, содержащие ингибиторы гликозидазы

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6589954B1 (en) 1998-05-22 2003-07-08 Scios, Inc. Compounds and methods to treat cardiac failure and other disorders
IL146309A (en) 1999-05-21 2008-03-20 Scios Inc Derivatives of the indole type and pharmaceutical preparations containing them as inhibitors of kinase p38
DE19934432A1 (de) * 1999-07-22 2001-02-01 Merck Patent Gmbh Indolderivate
DE19934433A1 (de) * 1999-07-22 2001-01-25 Merck Patent Gmbh N-(Indolcarbonyl-)piperazinderivate
US8465468B1 (en) 2000-06-29 2013-06-18 Becton, Dickinson And Company Intradermal delivery of substances
US20020156453A1 (en) * 1999-10-14 2002-10-24 Pettis Ronald J. Method and device for reducing therapeutic dosage
US20020095134A1 (en) * 1999-10-14 2002-07-18 Pettis Ronald J. Method for altering drug pharmacokinetics based on medical delivery platform
DE10102053A1 (de) * 2001-01-17 2002-07-18 Merck Patent Gmbh Piperazinylcarbonylchinoline und -isochinoline
MXPA03011638A (es) * 2001-06-15 2004-04-02 Hoffmann La Roche Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6.
CN1253220C (zh) * 2001-06-29 2006-04-26 贝克顿迪肯森公司 通过微管在真皮内输入疫苗和基因治疗剂
DE10157673A1 (de) * 2001-11-24 2003-06-05 Merck Patent Gmbh Verwendung von N-(Indolcarbonyl-)piperazinderivaten
GB0203811D0 (en) * 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
DE10212564B4 (de) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne
DE10217006A1 (de) * 2002-04-16 2003-11-06 Merck Patent Gmbh Substituierte Indole
EP1539241A2 (en) * 2002-08-30 2005-06-15 Becton, Dickinson and Company Method of controlling pharmacokinetics of immunomodulatory compounds
DE10246357A1 (de) * 2002-10-04 2004-04-15 Merck Patent Gmbh Verwendung von 5-HT2Rezeptorantagonisten
WO2005016401A2 (en) * 2003-06-13 2005-02-24 Becton Dickinson And Company Improved intra-dermal delivery of biologically active agents
WO2005023328A2 (en) * 2003-08-26 2005-03-17 Becton Dickinson And Company Methods for intradermal delivery of therapeutics agents
WO2005091922A2 (en) * 2004-03-03 2005-10-06 Becton, Dickinson And Company Methods and devices for improving delivery of a substance to skin
CN101022806A (zh) * 2004-04-15 2007-08-22 萨马里坦药品公司 (4-烷基哌嗪基)(苯基)甲酮在治疗阿尔茨海默病中的应用
WO2005115360A2 (en) * 2004-05-11 2005-12-08 Becton, Dickinson And Company Formulations of anti-pain agents and methods of using the same
DE102004047517A1 (de) * 2004-09-28 2006-03-30 Merck Patent Gmbh Neuartige Kristallform von (3-Cyan-1H-indol-7-yl)-[4-(4-fluorphenethyl)-piperazin-1-yl]-methanon, Hydrochlorid
CN101119965B (zh) * 2004-12-21 2012-09-26 弗·哈夫曼-拉罗切有限公司 萘满和茚满衍生物及其用途
GT200600042A (es) 2005-02-10 2006-09-27 Aventis Pharma Inc Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a
CA2652215A1 (en) * 2006-05-05 2007-11-15 Merck Patent Gesellschaft Mit Beschraenkter Haftung Crystalline (3-cyano-1h-indol-7-yl)-[4-(4-fluorophenethyl)piperazin-1-yl]methanone phosphate
US7514433B2 (en) * 2006-08-03 2009-04-07 Hoffmann-La Roche Inc. 1H-indole-6-yl-piperazin-1-yl-methanone derivatives
CA2686926C (en) 2007-05-14 2016-01-05 Sk Holdings Co., Ltd. Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
EP2008656A1 (en) * 2007-06-28 2008-12-31 Bergen Teknologioverforing AS Compositions for the treatment of hyperphenylalaninemia
ES2421237T7 (es) * 2007-08-15 2013-09-30 Arena Pharmaceuticals, Inc. Derivados de imidazo[1,2-a]piridin como moduladores del receptor serotoninérgico 5ht2a en el tratamiento de trastornos relacionados con el mismo
KR101062376B1 (ko) * 2008-04-10 2011-09-06 한국화학연구원 신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물
US9308323B2 (en) 2011-11-15 2016-04-12 Smiths Medical Asd, Inc. Systems and methods for illuminated medical tubing detection and management indicating a characteristic of at least one infusion pump
RU2549963C1 (ru) * 2014-04-08 2015-05-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Дальневосточный государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО "ДВГМУ" Минздрава России) Способ прогнозирования развития критической печеночной недостаточности на основании сывороточного уровня селена
GB2554371B (en) * 2016-09-22 2019-10-09 Resolute Energy Solutions Ltd Well apparatus and associated methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI101601B (fi) 1987-09-24 1998-07-31 Jencap Res Ltd Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmist een valmistusmenetelmässä
US5093341A (en) * 1987-12-17 1992-03-03 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine derivatives useful as antithrombolytic agents
US5032604A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Class III antiarrhythmic agents
US5032598A (en) 1989-12-08 1991-07-16 Merck & Co., Inc. Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
US5330986A (en) 1992-11-24 1994-07-19 Hoechst-Roussel Pharmaceuticals Inc. Indole-7-carboxamide derivatives
ZA954689B (en) 1994-06-08 1996-01-29 Lundbeck & Co As H 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines
WO1998006715A1 (en) 1996-08-09 1998-02-19 Smithkline Beecham Corporation Novel piperazine containing compounds
GB9718712D0 (en) 1997-09-03 1997-11-12 Merck Sharp & Dohme Theraputic Agents
DE19934433A1 (de) * 1999-07-22 2001-01-25 Merck Patent Gmbh N-(Indolcarbonyl-)piperazinderivate
DE19934432A1 (de) * 1999-07-22 2001-02-01 Merck Patent Gmbh Indolderivate
JPWO2005099240A1 (ja) * 2004-04-07 2008-03-06 松下電器産業株式会社 情報交換支援装置、情報交換支援方法、及び情報交換支援プログラム

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Ф.П.Тринус "Фармако-терапевтический справочник" 1989, Киев, "Здоровья", с.13-29. *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12398130B2 (en) 2016-02-25 2025-08-26 Asceneuron Sa Acid addition salts of piperazine derivatives
RU2851014C2 (ru) * 2021-07-05 2025-11-17 Феррер Интернасионал, С.А. Лекарственные средства, содержащие ингибиторы гликозидазы

Also Published As

Publication number Publication date
WO2001007435A3 (de) 2001-08-16
PL201893B1 (pl) 2009-05-29
JP2003505458A (ja) 2003-02-12
PT1198453E (pt) 2003-08-29
CN1364157A (zh) 2002-08-14
KR20020019513A (ko) 2002-03-12
AU6270400A (en) 2001-02-13
DK1198453T3 (da) 2003-07-21
NO20020307D0 (no) 2002-01-21
AR024819A1 (es) 2002-10-23
US20050096330A1 (en) 2005-05-05
HUP0201988A2 (hu) 2002-11-28
UA73518C2 (en) 2005-08-15
CN1229345C (zh) 2005-11-30
EP1198453B9 (de) 2004-11-10
CA2383779C (en) 2011-03-29
WO2001007435A2 (de) 2001-02-01
CA2383779A1 (en) 2001-02-01
CZ300510B6 (cs) 2009-06-03
EP1198453A2 (de) 2002-04-24
US7084143B2 (en) 2006-08-01
AU770411B2 (en) 2004-02-19
HUP0201988A3 (en) 2003-12-29
ES2192535T3 (es) 2003-10-16
CZ200268A3 (cs) 2002-04-17
MXPA02000730A (es) 2002-08-20
ZA200201486B (en) 2003-07-30
BR0012607A (pt) 2002-04-09
SK286066B6 (sk) 2008-02-05
KR100779207B1 (ko) 2007-11-27
NO322154B1 (no) 2006-08-21
MY122531A (en) 2006-04-29
ATE236877T1 (de) 2003-04-15
SK512002A3 (en) 2002-05-09
DK1198453T5 (da) 2005-01-31
JP5242871B2 (ja) 2013-07-24
DE50001729D1 (de) 2003-05-15
NO20020307L (no) 2002-03-21
PL353446A1 (en) 2003-11-17
DE19934433A1 (de) 2001-01-25
US6838461B1 (en) 2005-01-04
JP2012006940A (ja) 2012-01-12
EP1198453B1 (de) 2003-04-09
HK1048636B (zh) 2006-08-11
HK1048636A1 (en) 2003-04-11

Similar Documents

Publication Publication Date Title
JP5242871B2 (ja) N−(インドールカルボニル)ピペラジン誘導体
US6723725B1 (en) Indole derivatives
KR100854481B1 (ko) 피페라진일카르보닐퀴놀린 및 ­이소퀴놀린

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20110708